Research Analyst at Goldman Sachs Group Inc.
Sarah Chen is currently an analyst at Goldman Sachs specializing in healthcare sector research. While holding the position of analyst, she focuses on coverage across key healthcare companies and industries, conducting in-depth commercial analytics and quantitative research as part of her mandate. Chen began her professional journey directly at Goldman Sachs after graduating, building expertise in commercial analytics and data-driven healthcare research. She is registered with FINRA, holding relevant securities licenses for her analytical role, and is recognized internally for her rigorous data analysis and research contributions, though publicly available performance metrics and rankings are not disclosed.
Sarah Chen inquired about the specific technological improvements in the third-generation robots and how these enhancements drive both revenue and cost efficiencies.
CEO Ali Kashani detailed that Gen 3 robots feature 70% more battery, double the speed, and 5x more compute power, which increases delivery capacity and efficiency. He also highlighted that robot costs were halved through in-house component manufacturing, design optimization, and economies of scale.
Ask complex financial questions and get precise answers in seconds. Fintool scans millions of documents to surface insights beyond timely human analysis.
Trusted by leading investment firms and analysts